SCHEMBL1007527

SCHEMBL1007527

CCOC(=O)c1csc2c1CCNC2=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.47
MAPK1 P28482 2/20 0.47
USP2 O75604 1/20 0.47
HTT P42858 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
CDK5 Q00535 8/20 0.46
MAPK8 P45983 3/20 0.46
DYRK1A Q13627 3/20 0.46
CLK4 Q9HAZ1 3/20 0.46
DAPK3 O43293 2/20 0.46
PRKD3 O94806 2/20 0.46
MAP4K4 O95819 2/20 0.46
PIM1 P11309 2/20 0.46
CLK2 P49760 2/20 0.46
GSK3B P49841 2/20 0.46
AURKB Q96GD4 2/20 0.46
PLK4 O00444 1/20 0.46
DYRK3 O43781 1/20 0.46
JAK2 O60674 1/20 0.46
RPS6KB1 P23443 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5358780 0.78 ALDH1A1 (0.54) ALDH1A1TDP1MAPTKMT2AKDM4E
SCHEMBL1425934 0.75 ADORA1 (0.50) ALDH1A1MAPK1USP2HTTTDP1
SCHEMBL5358551 0.75 L3MBTL1 (0.40) ALDH1A1HTTTDP1CDK5MAPT
SCHEMBL1008018 0.75 MEN1 (0.41) ALDH1A1MAPK1HTTMAPTKMT2A
SCHEMBL6318336 0.74 ADORA1 (0.59) ALDH1A1MAPK1USP2HTTTDP1
Hydrochloric Acid SCHEMBL27076945 0.73 ADORA1 (0.60) ALDH1A1MAPK1USP2HTTTDP1
SCHEMBL14341897 0.72 SMN1; SMN2 (0.44) ALDH1A1MAPK1USP2TDP1MAPT
Hydrochloric Acid SCHEMBL27077024 0.71 ADORA1 (0.38) ALDH1A1MAPTKMT2AKDM4ETP53
Hydrochloric Acid SCHEMBL27076956 0.71 L3MBTL1 (0.38) ALDH1A1TDP1MAPTKMT2AKDM4E
Hydrochloric Acid SCHEMBL29116104 0.71 L3MBTL1 (0.38) ALDH1A1TDP1MAPTKMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110118236-A1 HETEROCYCLIC COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-05-19 US disclosed
EP-2269990-A1 HETEROCYCLIC COMPOUND Takeda Pharmaceutical Company Limited (JP) 2011-01-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110118236-A1 HETEROCYCLIC COMPOUND GRIN1, GRM1, GRIK1 ALDH1A1 614/4885MAPK1 797/4885USP2 4641/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.